机构

• 上海药物研究所 [132]
• 西北高原生物研究所 [19]
• 昆明植物研究所 [15]
• 金属研究所 [14]
• 成都生物研究所 [7]
• 新疆理化技术研究所 [6]
• 更多

采集方式

• OAI收割 [252]
• iSwitch采集 [5]

内容类型

• 期刊论文 [251]
• 会议论文 [3]
• 学位论文 [3]

发表日期

• 2024 [4]
• 2023 [12]
• 2022 [19]
• 2021 [16]
• 2020 [10]
• 2019 [14]
• 更多

学科主题

• Pharmacolo... [8]
• Chemistry [4]
• Chemistry,... [4]
• 生命有机化学 [3]
• Biochemist... [2]
• Food Scien... [2]
• 更多

筛选

浏览/检索结果: 共257条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Functional structural domain synthesis of anti-pancreatic carcinoma pectin-like polysaccharide RN1 期刊论文  OAI收割 CARBOHYDRATE POLYMERS, 2024, 卷号: 327, 页码: 11 作者:  Cai, Deqin;  He, Fei;  Wu, Shengjie;  Wang, Zixuan;  Bian, Ya   |  收藏  |  浏览/下载：13/0  |  提交时间：2024/02/19 Polysaccharide  Pectin  Functional structural domain  Pancreatic cancer  Glycan synthesis  RN1   Structure-Activity Relationships of 2-(Arylthio)benzoic Acid FTO Inhibitors 期刊论文  OAI收割 ISRAEL JOURNAL OF CHEMISTRY, 2024, 页码: 13 作者:  Yan, Chao;  Zhang, Qian;  Xiao, Pan;  Xie, Xinyun;  Li, Ming   |  收藏  |  浏览/下载：29/0  |  提交时间：2024/03/25 RNA modification  m(6)A  FTO  anticancer   Development of Potent MALT1 Inhibitors Featuring a Novel "2-Thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidin-7(6H)-one" Scaffold for the Treatment of B Cell Lymphoma 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 67, 期号: 4, 页码: 2884-2906 作者:  Liang, Xuewu;  Yu, Haolan;  Liang, Renwen;  Feng, Zhuanghui;  Saidahmatov, Abdusaid   |  收藏  |  浏览/下载：15/0  |  提交时间：2024/04/09 Discovery and Optimization of WDR5 Inhibitors via Cascade Deoxyribonucleic Acid-Encoded Library Selection Approach 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 67, 期号: 2, 页码: 1079-1092 作者:  Qin, Shaozhao;  Feng, Lijian;  Zhao, Qingyi;  Yan, Ziqin;  Lyu, Xilin   |  收藏  |  浏览/下载：17/0  |  提交时间：2024/02/27 Discovery of 5-trifluoromethyl-2-aminopyrimidine derivatives as potent dual inhibitors of FLT3 and CHK1 期刊论文  OAI收割 RSC MEDICINAL CHEMISTRY, 2023, 页码: 14 作者:  Deng, Minjie;  Gao, Yue;  Wang, Peipei;  Du, Wenjing;  Xu, Gaoya   |  收藏  |  浏览/下载：7/0  |  提交时间：2024/02/19 Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 259, 页码: 19 作者:  Wang, Pingyuan;  Zhu, Wen-Ting;  Wang, Yajing;  Song, Shan-Shan;  Xi, Yong   |  收藏  |  浏览/下载：58/0  |  提交时间：2023/10/17 PARP1 inhibitor  Synthetic lethality  Drug resistance  Anticancer  Structure -activity relationship   Design, synthesis, and biological evaluation of novel spirocyclic compounds as potential anti-glioblastoma agents 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 258, 页码: 22 作者:  Zhu, Heping;  Song, Xiaomin;  Pan, Yihui;  Li, Ming;  Chen, Liang   |  收藏  |  浏览/下载：11/0  |  提交时间：2023/10/17 Glioblastoma  Spirocyclic compounds  Drug design  Antiproliferation   A zinc-modified Anemarrhena asphodeloides polysaccharide complex enhances immune activity via the NF-?B and MAPK signaling pathways 期刊论文  OAI收割 INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 卷号: 249, 页码: 12 作者:  Zhang, Shaojie;  Zhang, Qian;  Li, Chong;  Xing, Na;  Zhou, Pengfei   |  收藏  |  浏览/下载：8/0  |  提交时间：2023/12/08 Anemarrhena asphodeloides Bunge  Zinc modification  Immunoregulatory activity  Zebrafish  NF-kappa B signaling pathway  MAPKs signaling pathway   Exploration of novel four-membered-heterocycle constructed peptidyl proteasome inhibitors with improved metabolic stability for cancer treatment 期刊论文  OAI收割 BIOORGANIC CHEMISTRY, 2023, 卷号: 138, 页码: 22 作者:  Wang, Hanlin;  Wu, Zhaoxiao;  Cao, Yu;  Gao, Lixin;  Shao, Jiaan   |  收藏  |  浏览/下载：13/0  |  提交时间：2023/10/17 Metabolic stability  Four-membered heterocycles  Proteasome inhibitors  Multiple myeloma   Design, synthesis and pharmacological evaluation of 2,3-dihydrobenzo-furan IRAK4 inhibitors for the treatment of diffuse large B-cell lymphoma 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 256, 页码: 16 作者:  Chen, Yun;  Ning, Yi   |  收藏  |  浏览/下载：11/0  |  提交时间：2023/10/17 Apoptosis  Diffuse large B-Cell lymphoma  Interleukin-1 receptor associated kinase 4  Structure-based drug design  2  3-Dihydrobenzofuran